________
Flashback: USAID is "pimping" Big Pharma in Africa for big profits and control (with a little help from Bill Gates)
By Phil Butler | New Eastern Outlook | November 6, 2019
USAID has just awarded $160 million to the United States Pharmacopeia (USP) for a cooperative agreement to regulate the pharmaceutical landscape in Africa. U.S. taxpayers are now funding a U.S. State Department approved plan developed so our government can help big pharma pimps. Here's a look inside USP and this latest USAID plan.
Pharma Pimps
If you scan the Board of Trustees of the NGO USP you will immediately run into BIG BUSINESS shining like the sleazy glow from some red-light district brothel in Paris or New Orleans. Aventis, Bristol-Myers Squibb Company, India's Laurus Labs, Eli Lilly & Company, Pfizer, Pharmacia, Upjohn, France's Sanofi, and all the likely suspects are proudly listed in plain sight. The agri-giants are there too, smiling out at you like comic book villains from DC or Marvel. There's FSG consulting executives proud to have been solving the world's problems since the Soviet Union fell. FDA Chief Scientists are listed, and so are Washington regulatory specialists (and lobbyists) representing firms like Greenleaf Health Inc.
Ronald T. Piervincenzi, Ph.D., the CEO of USP could serve as the poster boy for big pharma and big Agra businesses. Ronald's major in college way biomedical engineering. Ronald now sets the standards for most every medication sold in the United States. He got his start at Hofstra University on Long Island and from visits to the Naval Research Laboratory in Washington DC. He went to Duke University and got a "magical" full-time position with McKinsey & Company. You can read the rest of "Ron Piervincenzi: A Series of Fortunate Events" here.
You can see Ron here in Nigeria alongside USAID in Nigeria when the National Agency for Food and Drug Administration and Control (NAFDAC) Kaduna laboratory was accreditated in 2017. At first glance, USP and USAID efforts appear viable, straightforward, and even altruistic and noble. This is from the press release on the most recent USAID-USP effort in Africa:
A Policy for Everyone and for Everything
The USP-USAID efforts in Africa have already led to a Kenya, Ghana and Malawi launch of the world's first malaria vaccine. The vaccine, RTS,S, was first developed at the U.S. Army's Walter Reed Army Institute for Research back in January 2001. According to the literature, it is the first and only vaccine to significantly fight malaria in children. RTS,S is to a great degree, a project of the Bill & Melinda Gates Foundation. PATH, an NGO funded by the foundation, partnered with GSK, which one of the world's leading research-based pharmaceutical and healthcare companies in getting the pilot programs started in Sub-Saharan Africa. GlaxoSmithKline (GSK), is the sixth biggest pharma company in the world.
Some readers may recall, it was GSK that pleaded guilty to promotion of drugs for unapproved uses, failure to report safety data, and kickbacks to physicians in the United States back in 2012. The company forked over $3 billion (£1.9bn) in a settlement, the largest health-care fraud case, the largest settlement by a drug company.
I know it will make readers sleep better knowing that USP and USAID are on our side in partnering with transparent and reputable companies (I had to say it). I'd be negligent if I failed to point out that GSK Board Director, Dr. Jesse Goodman of GSK, is also President and Member of the Board of the United States Pharmacopeia (USP) and as a member of the Regulatory Working Group of the Coalition for Epidemic Preparedness Innovations (CEPI).
I mentioned the NGO PATH and its role in this Africa initiative. Another company associated with a USP trustee, Sanofi announced the release of 1.7 million doses of Sanofi's ArteSunate AmodiaQuine Winthrop (ASAQ Winthrop), announced 300 million treatments shipped to African countries since 2007.
Total funding for malaria control and elimination reached an estimated US$ 3.1 billion in 2017, and much of that was provided by governments. The U.S. provided $1.2 billion. From 2016 to 2017, the 10 highest-burden countries in Africa reported increases in cases of malaria. And malaria vaccines are only one class of drugs USAID and the USP are working to "control" in Africa. On the market side of things, this one class represents a $156.8 million dollar market by the year 2026, according to Marketwatch.
So, governments, philanthropists, NGOs, and taxpayers are helping companies like GSK not only to develop the drugs, but to do the marketing, distribution, and eventual sale of the drugs as well. Multiply malaria vaccines times hundreds of regulated preventions and cures. Now add in other programs and USAID influence in the region.
For instance, PATH is leading a five-year project to improve the health and development of 750,000 pregnant women and children by encouraging breastfeeding and improving health care for pregnant women and young children. Back in 2012, PATH was in the news for the Indian government claiming the NGO's HPV vaccine resulted in the alleged death of seven girls belonging to an indigenous community (tribe) in India. Allegedly, 2,800 consent forms for the trials were signed by a hostel warden or headmaster, as the 'guardian'. And now we know why USP is needed, I guess.
Please go to SOTT to continue reading.
If you scan the Board of Trustees of the NGO USP you will immediately run into BIG BUSINESS shining like the sleazy glow from some red-light district brothel in Paris or New Orleans. Aventis, Bristol-Myers Squibb Company, India's Laurus Labs, Eli Lilly & Company, Pfizer, Pharmacia, Upjohn, France's Sanofi, and all the likely suspects are proudly listed in plain sight. The agri-giants are there too, smiling out at you like comic book villains from DC or Marvel. There's FSG consulting executives proud to have been solving the world's problems since the Soviet Union fell. FDA Chief Scientists are listed, and so are Washington regulatory specialists (and lobbyists) representing firms like Greenleaf Health Inc.
Ronald T. Piervincenzi, Ph.D., the CEO of USP could serve as the poster boy for big pharma and big Agra businesses. Ronald's major in college way biomedical engineering. Ronald now sets the standards for most every medication sold in the United States. He got his start at Hofstra University on Long Island and from visits to the Naval Research Laboratory in Washington DC. He went to Duke University and got a "magical" full-time position with McKinsey & Company. You can read the rest of "Ron Piervincenzi: A Series of Fortunate Events" here.
You can see Ron here in Nigeria alongside USAID in Nigeria when the National Agency for Food and Drug Administration and Control (NAFDAC) Kaduna laboratory was accreditated in 2017. At first glance, USP and USAID efforts appear viable, straightforward, and even altruistic and noble. This is from the press release on the most recent USAID-USP effort in Africa:
"To achieve the goal of PQM+, USP and its partners will work to strengthen governance and regulatory structures, optimize the allocation and use of resources, improve the supply of quality-assured medical products...."USP and USAID capitalize on the problems of bad or illegitimate drugs administered for tough diseases like malaria. Here's where our story gets interesting.
A Policy for Everyone and for Everything
The USP-USAID efforts in Africa have already led to a Kenya, Ghana and Malawi launch of the world's first malaria vaccine. The vaccine, RTS,S, was first developed at the U.S. Army's Walter Reed Army Institute for Research back in January 2001. According to the literature, it is the first and only vaccine to significantly fight malaria in children. RTS,S is to a great degree, a project of the Bill & Melinda Gates Foundation. PATH, an NGO funded by the foundation, partnered with GSK, which one of the world's leading research-based pharmaceutical and healthcare companies in getting the pilot programs started in Sub-Saharan Africa. GlaxoSmithKline (GSK), is the sixth biggest pharma company in the world.
Some readers may recall, it was GSK that pleaded guilty to promotion of drugs for unapproved uses, failure to report safety data, and kickbacks to physicians in the United States back in 2012. The company forked over $3 billion (£1.9bn) in a settlement, the largest health-care fraud case, the largest settlement by a drug company.
I know it will make readers sleep better knowing that USP and USAID are on our side in partnering with transparent and reputable companies (I had to say it). I'd be negligent if I failed to point out that GSK Board Director, Dr. Jesse Goodman of GSK, is also President and Member of the Board of the United States Pharmacopeia (USP) and as a member of the Regulatory Working Group of the Coalition for Epidemic Preparedness Innovations (CEPI).
I mentioned the NGO PATH and its role in this Africa initiative. Another company associated with a USP trustee, Sanofi announced the release of 1.7 million doses of Sanofi's ArteSunate AmodiaQuine Winthrop (ASAQ Winthrop), announced 300 million treatments shipped to African countries since 2007.
Total funding for malaria control and elimination reached an estimated US$ 3.1 billion in 2017, and much of that was provided by governments. The U.S. provided $1.2 billion. From 2016 to 2017, the 10 highest-burden countries in Africa reported increases in cases of malaria. And malaria vaccines are only one class of drugs USAID and the USP are working to "control" in Africa. On the market side of things, this one class represents a $156.8 million dollar market by the year 2026, according to Marketwatch.
So, governments, philanthropists, NGOs, and taxpayers are helping companies like GSK not only to develop the drugs, but to do the marketing, distribution, and eventual sale of the drugs as well. Multiply malaria vaccines times hundreds of regulated preventions and cures. Now add in other programs and USAID influence in the region.
For instance, PATH is leading a five-year project to improve the health and development of 750,000 pregnant women and children by encouraging breastfeeding and improving health care for pregnant women and young children. Back in 2012, PATH was in the news for the Indian government claiming the NGO's HPV vaccine resulted in the alleged death of seven girls belonging to an indigenous community (tribe) in India. Allegedly, 2,800 consent forms for the trials were signed by a hostel warden or headmaster, as the 'guardian'. And now we know why USP is needed, I guess.
Please go to SOTT to continue reading.
________
Related to all of the recent events taking place in Washington DC including USAID:
USAID and political subversion (capturing markets) of various countries including Cuba and Venezuela:
Pretty much most investigators and observers have always known the USAID is a CIA front:
A few words on Elon Musk and USAID. Nothing is about politics although that is what you are led to think. It is all about power, money and greed:
Understand the USAID is ultimately directed by the British Crown Agents controlling much of USAID's technical assistance:
No comments:
Post a Comment
Note: Only a member of this blog may post a comment.